| scholarly article | Q13442814 |
| P2093 | author name string | Antonio Di Gennaro | |
| Jesper Z. Haeggström | |||
| P2860 | cites work | Characterization of the human cysteinyl leukotriene CysLT1 receptor | Q22010199 |
| A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis | Q24308699 | ||
| P304 | page(s) | 51-92 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Advances in Immunology | Q15752932 |
| P1476 | title | The Leukotrienes: Immune-Modulating Lipid Mediators of Disease |
| Q48149704 | 5-/12-Lipoxygenase-linked cascade contributes to the IL-33-induced synthesis of IL-13 in mast cells, thus promoting asthma development. |
| Q34208803 | 5-Lipoxygenase inhibitors attenuate TNF-α-induced inflammation in human synovial fibroblasts |
| Q28294597 | A review on leukotrienes and their receptors with reference to asthma |
| Q92604715 | Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis |
| Q60409294 | An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness. |
| Q46248584 | Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis. |
| Q58691455 | Asthma is associated with carotid arterial injury in children: The Childhood Origins of Asthma (COAST) Cohort |
| Q35637447 | Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis |
| Q24631264 | BLT2 is a pro-tumorigenic mediator during cancer progression and a therapeutic target for anti-cancer drug development |
| Q33822645 | Biofluid lipidome: a source for potential diagnostic biomarkers |
| Q39147426 | Critical Role of LTB4/BLT1 in IL-23-Induced Synovial Inflammation and Osteoclastogenesis via NF-κB. |
| Q33757657 | Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function |
| Q35649907 | EETs Attenuate Ox-LDL-Induced LTB4 Production and Activity by Inhibiting p38 MAPK Phosphorylation and 5-LO/BLT1 Receptor Expression in Rat Pulmonary Arterial Endothelial Cells |
| Q27003139 | Eicosanoids and Keratinocytes in Wound Healing |
| Q36071775 | Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk |
| Q38298369 | Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors |
| Q37142660 | Evolutionary alteration of ALOX15 specificity optimizes the biosynthesis of antiinflammatory and proresolving lipoxins |
| Q42670355 | Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors. |
| Q38972336 | Genetic polymorphisms of T-1131C APOA5 and ALOX5AP SG13S114 with the susceptibility of ischaemic stroke in Morocco |
| Q28392474 | Late-Onset Asthma Predicts Cardiovascular Disease Events: The Wisconsin Sleep Cohort |
| Q44652440 | Leukotriene B(4): a lipid at the heart of inflammation |
| Q28270881 | Leukotriene C4 is the major trigger of stress-induced oxidative DNA damage |
| Q47153085 | Leukotrienes and kidney diseases |
| Q27023936 | Lipid mediators and allergic diseases |
| Q30370370 | Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection. |
| Q92371170 | Mechanisms linking bovine viral diarrhea virus (BVDV) infection with infertility in cattle |
| Q39049264 | Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents |
| Q36936203 | Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays |
| Q37636944 | Recent developments in the role of reactive oxygen species in allergic asthma |
| Q92733040 | Role of Leukotriene B4 Receptor-2 in Mast Cells in Allergic Airway Inflammation |
| Q39245385 | Role of stem cell growth factor/c-Kit in the pathogenesis of irritable bowel syndrome |
| Q42087526 | Strain-specific red blood cell storage, metabolism, and eicosanoid generation in a mouse model. |
| Q37707902 | The development of novel LTA4H modulators to selectively target LTB4 generation. |
| Q90277653 | The mercapturomic profile of health and non-communicable diseases |
Search more.